公司资料
Merrimack 股价、新闻与催化剂
- 股票代码:
- MACK
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for MACK.
公司概览
业务概览
Merrimack was an oncology company focused on targeted cancer medicines before its corporate restructuring and delisting history. Its legacy was tied to the challenge of turning oncology science into commercial value.
所在地与行业分类
Headquartered in the United States and formerly listed on NASDAQ, Merrimack sat in oncology biotechnology.
商业模式特征
The business depended on clinical development, commercialization execution, and strategic portfolio decisions.
生物医药行业定位
Merrimack belongs to the historical oncology-biotech category rather than the current public-company set.
未来催化剂
- Merrimack’s catalysts are zenocutuzumab royalties and any remaining oncology development or monetization update. The market will watch whether the company can keep turning a concentrated asset base into visible value.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。